Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Oligometastatic Renal Cell Carcinoma × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5640 Carcinoma, Renal Cell 1700 Urinary Bladder Neoplasms 1493 Kidney Neoplasms 825 Neoplasms 700 Breast Neoplasms 697 Carcinoma, Transitional Cell 514 Carcinoma, Non-Small-Cell Lung 461 Neoplasm Metastasis 453 Melanoma 419 Ovarian Neoplasms 404 Colorectal Neoplasms 399 Lung Neoplasms 381 Pancreatic Neoplasms 282 Testicular Neoplasms 250 Sarcoma 242 Non-Muscle Invasive Bladder Neoplasms 231 Stomach Neoplasms 230 Uterine Cervical Neoplasms 223 Head and Neck Neoplasms 208 Colonic Neoplasms 185 Wilms Tumor 177 Esophageal Neoplasms 177 Squamous Cell Carcinoma of Head and Neck 175 Endometrial Neoplasms 167 Carcinoma, Hepatocellular 165 Recurrence 143 Neuroblastoma 135 Small Cell Lung Carcinoma 124 Multiple Myeloma 122

Interventions

pembrolizumab 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05578664 2023-08-30

PE-PE

Consorzio Oncotech

Phase 2 Unknown

Oligometastatic Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡